Image via Wikipedia
On any given day, an estimated 6000 Americans who need a bone marrow transplant are searching the country’s donor banks hoping to find the right match.
For many of those patients, especially minorities, the odds of finding an outside donor have been pretty low. But, that is starting to change. There is new research that suggests the donor pool may be widening.
Just shy of his second birthday, little Elmor Bonilla has overcome obstacles and odds most people don’t face over a lifetime.
Elmor was born with Krabbe disease; a rare and often fatal disorder that attacks the central nervous
Stem Cell Therapy
Stem cell banking is gaining popularity in Indore and Bhopal as increasing numbers of parents are taking to the concept, which has the potential to secure their child’s healthy life.
The number of people who have registered for stem cell banking has increased multifold in Indore and Bhopal, placing them among the top 10 cities in the country, according to industry estimates.
Every month about 500 parents from Indore and Bhopal are investing in the potential life-saving power of stem cells by preserving the umbilical cord at child birth, whose stem cells help fight against any future life
In a first, scientists have grown artificial skin using stem cells derived from the umbilical cord.
Scientists from the Tissue Engineering Research Group at the Department of Histology at the University of Granada demonstrated the ability of Wharton jelly mesenschymal stem cells to turn to oral-mucosa or skin-regeneration epithelia.
Image via Wikipedia
Colin McGuckin, professor of regenerative medicine at the University of Newcastle and adult stem cell expert has said that government funding goes mostly to embryonic stem cells despite the fact that his work gives immediate practical results.
He has also complained that the university is not able to provide him with adequate structures to carry out his research, adding, “There aren’t many people in the city that know that there is research on adult stem cells.”
The professor, who is a Catholic, is a pioneer in umbilical cord stem cells research, with a study that creates tissue for
Fondazione IRCCS Istituto Nazionale Tumori di Milano
Methods to provide safer stem cell transplants to individuals who are not completely compatible with the donor are being developed. Encouraging results have come from a post-transplant cellular therapy, which strengthens the immune system against viral infections and tumors, developed for the first time at the National Tumor Institute (INT) in Milan. The INT conducted the first phase I-II study in the world, published in ‘Blood’, whose main objective was to assess the use of a low dose radiochemotherapy, followed by low dose post-transplant infusions CD8-depleted donor lymphocytes after